StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
12
Publishing Date
2023 - 10 - 24
10
2023 - 10 - 04
8
2023 - 05 - 19
9
2023 - 05 - 02
13
2022 - 06 - 13
12
2022 - 05 - 19
9
2022 - 05 - 03
9
2022 - 04 - 25
9
2022 - 03 - 01
11
2022 - 02 - 17
8
2022 - 02 - 15
9
2022 - 01 - 06
8
2022 - 01 - 04
9
2021 - 12 - 20
9
2021 - 12 - 14
8
2021 - 12 - 13
12
2021 - 12 - 09
10
2021 - 12 - 01
8
2021 - 11 - 12
21
2021 - 11 - 11
8
2021 - 11 - 09
12
2021 - 11 - 08
8
2021 - 11 - 04
9
2021 - 11 - 02
10
2021 - 10 - 22
9
2021 - 10 - 21
12
2021 - 10 - 20
12
2021 - 10 - 14
8
2021 - 10 - 12
10
2021 - 10 - 04
13
2021 - 10 - 01
24
2021 - 09 - 15
8
2021 - 09 - 09
8
2021 - 07 - 19
8
2021 - 06 - 23
8
2021 - 06 - 17
8
2021 - 06 - 10
13
2021 - 06 - 07
8
2021 - 06 - 04
11
2021 - 06 - 03
9
2021 - 05 - 12
9
2021 - 05 - 11
8
2021 - 05 - 10
8
2021 - 05 - 04
7
2021 - 04 - 28
8
2021 - 04 - 27
14
2021 - 04 - 26
8
2021 - 04 - 23
7
2021 - 04 - 20
7
2021 - 04 - 19
7
2021 - 04 - 13
9
2021 - 04 - 12
9
2021 - 03 - 29
7
2021 - 03 - 23
7
2021 - 03 - 15
7
2021 - 03 - 08
7
2021 - 01 - 19
13
2021 - 01 - 04
7
2020 - 12 - 21
7
2020 - 12 - 08
8
Sector
Health technology
9
Manufacturing
1
Producer manufacturing
1
Tags
Acquisition
12
Acquisition corp
6
Alliances
5
Antibody
4
Application
4
Bio-nc
4
Biocapital
4
Biopharma
5
Biotech
9
Biotech-bay
4
Biotech-beach
9
Brands
4
Cancer
13
Car-t
4
Ceo
5
China
5
Clinical trials
4
Collaboration
9
Commercialization
4
Conference
68
Contract
4
Covid
5
Designation
7
Device
5
Disease
6
Distribution
5
Earnings
14
Ema
9
Energy
8
Europe
6
Events
16
Expansion
5
Eye
4
Financial results
71
Food
4
Growth
16
Immunotherapy
7
Iot
13
Liver
5
Merge
5
N/a
431
Offering
20
Pharma
4
Phase 1
6
Phase 2
5
Phase 3
5
Platform
11
Positive
7
Pre-clinical
4
Presentation
6
Research
16
Results
117
Security
5
Technology
14
Therapeutics
9
Therapy
12
Treatment
6
Trial
16
Trials
5
Vaccine
5
Entities
3m company
1
Amplitude healthcare acquisition corp
1
Aravive, inc.
1
Atyr pharma, inc.
1
Avrobio, inc.
1
Compass pathways plc
1
Immunocore holdings plc - adr
1
Intra-cellular therapies inc.
1
Iovance biotherapeutics, inc.
1
Nektar therapeutics
1
Parker-hannifin corporation
1
Poseida therapeutics, inc.
1
Precision biosciences, inc.
1
Renovorx inc
1
Symbols
ARAV
1
AVRO
1
CMPS
1
DTIL
1
IMCR
1
IOVA
1
ITCI
1
JSPR
1
LIFE
1
MMM
1
NKTR
1
PH
1
PSTX
1
RNXT
1
Exchanges
Nasdaq
11
Nyse
1
Crawled Date
2021 - 11 - 10
1
2021 - 11 - 09
11
Crawled Time
11:00
1
12:15
1
12:26
1
13:00
1
13:15
1
14:00
1
14:15
1
15:15
1
17:00
1
19:00
3
Source
renovorx.com
1
www.biospace.com
6
www.globenewswire.com
3
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 11 - 09
tags :
Therapy
save search
Presentation During New Advances in the Management of Pancreatic Cancer Course Highlights Intra-Arterial Chemotherapy as a Potential Innovative Treatment for Pancreatic Cancer
Published:
2021-11-09
(Crawled : 12:26)
- renovorx.com
RNXT
|
$1.23
0.82%
0.81%
20K
|
|
-78.37%
|
O:
67.28%
H:
38.23%
C:
-9.83%
presentation
treatment
potential
therapy
cancer
pancreatic
pancreas
Aravive Announces Positive Preliminary Data from Phase 1b Trial Evaluating Batiraxcept (AVB-500) in Combination with Cabozantinib in Clear Cell Renal Cell Carcinoma to be Presented at 2021 Society for Immunotherapy of Cancer Annual Meeting
Published:
2021-11-09
(Crawled : 19:00)
- biospace.com/
ARAV
|
$0.0401
4.74%
4M
|
Health Technology
|
-98.86%
|
O:
1.47%
H:
2.91%
C:
-2.42%
immunotherapy
phase 1
renal
positive
therapy
cancer
phase 1b
trial
phase 2b
cell carcinoma
Immunocore presents new data on tebentafusp in metastatic cutaneous melanoma (mCM) and uveal melanoma (mUM) at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published:
2021-11-09
(Crawled : 19:00)
- biospace.com/
IMCR
|
$55.71
1.77%
1.74%
450K
|
Manufacturing
|
Email alert
Add to watchlist
immunotherapy
therapy
cancer
Jasper Therapeutics Announces Research Collaboration with AVROBIO to Evaluate JSP191 as Conditioning Agent in Clinical Studies of Ex Vivo Lentiviral Gene Therapy
Published:
2021-11-09
(Crawled : 19:00)
- biospace.com/
JSPR
|
$21.61
-6.89%
-7.4%
65K
|
|
134.16%
|
O:
-2.22%
H:
0.0%
C:
0.0%
AVRO
|
$1.205
-2.82%
-2.9%
39K
|
Health Technology
|
-80.46%
|
O:
-1.63%
H:
0.5%
C:
-3.64%
gene therapy
therapy
collaboration
research
aTyr Pharma Presents Research Demonstrating Effects of Novel NRP2-Targeting Antibody, ATYR2810, on Tumor Associated Macrophages at the Society for Immunotherapy of Cancer Annual Meeting
Published:
2021-11-09
(Crawled : 17:00)
- biospace.com/
LIFE
|
$1.6
-1.23%
-1.25%
160K
|
Health Technology
|
-81.07%
|
O:
-0.47%
H:
2.73%
C:
2.02%
immunotherapy
therapy
cancer
antibody
research
Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors with Cancer Specialist During 2021 Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published:
2021-11-09
(Crawled : 15:15)
- biospace.com/
NKTR
|
News
|
$1.265
-4.17%
-4.35%
4.7M
|
Health Technology
|
-91.54%
|
O:
-0.96%
H:
1.24%
C:
-4.76%
immunotherapy
therapy
cancer
conference
Precision BioSciences to Highlight Capabilities of ARCUS Gene Editing for Allogeneic CAR T Cell Immunotherapies at The Society for Immunotherapy of Cancer 36th Annual Meeting
Published:
2021-11-09
(Crawled : 14:15)
- biospace.com/
DTIL
|
$9.75
-9.05%
-9.95%
170K
|
Health Technology
|
-0.61%
|
O:
-2.04%
H:
0.0%
C:
0.0%
immunotherapy
therapy
cancer
arcus
car-t
t-cell
Iovance Biotherapeutics Announces Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Cell Therapy in Multiple Solid Tumors at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published:
2021-11-09
(Crawled : 14:00)
- globenewswire.com
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
-54.87%
|
O:
-0.36%
H:
4.65%
C:
-0.64%
immunotherapy
solid tumors
therapy
cancer
iot
Poseida Therapeutics to Present Preclinical Data Highlighting Fully Allogeneic CAR-T Product Candidates at the Society for Immunotherapy of Cancer 2021 Annual Meeting
Published:
2021-11-09
(Crawled : 13:15)
- prnewswire.com
PSTX
|
$2.02
1.0%
0.99%
640K
|
Health Technology
|
-70.7%
|
O:
-1.96%
H:
0.0%
C:
0.0%
immunotherapy
therapy
car-t
cancer
preclinical
pre-clinical
Intra-Cellular Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Published:
2021-11-09
(Crawled : 13:00)
- globenewswire.com
ITCI
1 d
|
$72.29
0.4%
0.4%
2.2M
|
Health Technology
|
60.25%
|
O:
-2.02%
H:
3.23%
C:
0.14%
financial results
results
therapy
COMPASS Pathways announces positive topline results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression
Published:
2021-11-09
(Crawled : 12:15)
- globenewswire.com
CMPS
|
$8.35
-0.83%
-0.84%
370K
|
Health Technology
|
-83.01%
|
O:
-17.57%
H:
3.31%
C:
-11.45%
treatment
positive
therapy
results
topline
depression
trial
comp360
psilocybin
Global Depth Filtration Market 2021-2026 - Depth Filtration Quickens Ascent to the Top of the Game in Gene Therapies
Published:
2021-11-09
(Crawled : 11:00)
- prnewswire.com
PH
|
$534.65
-0.64%
0.0%
560K
|
Producer Manufacturing
|
62.23%
|
O:
0.22%
H:
0.82%
C:
-0.22%
MMM
|
$92.27
0.86%
-0.18%
3.6M
|
Producer Manufacturing
|
-49.49%
|
O:
-0.71%
H:
0.0%
C:
0.0%
gene therapies
gene therapy
therapy
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.